A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemd patients with stage II/III multiple myeloma: a prospective randomised phototherapy with autologous stem-cell rescue in a newly diagnose

M (Michel) van Agthoven, C Segeren, Ivonne Buijt, Carin Uyl - de Groot, Ronnie van der Holt, HM Lokhorst, Pieter Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1159-1169
Number of pages11
JournalEuropean Journal of Cancer
Volume40
Publication statusPublished - 2004

Cite this